News | April 01, 2025
Shin-Etsu Chemical to invest in pharmaceutical cellulose business
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
The inspection has concluded with four observations
Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
The products will be manufactured in Goa India and marketed & distributed in Australian markets
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
Subscribe To Our Newsletter & Stay Updated
